Hospital CEO Advice

What straightforward tactic should clinical and operational leaders consider to make an impact on mortality and readmissions in fairly short order? Prioritize appointments within 7-14 days of discharge for high-risk patients. Watch this video as HDAI’s CEO Nassib Chamoun shares an example of how this strategy is working at a major academic medical center. Video […]
Nassib Chamoun’s Big Ideas for 2025

In 2025, health systems that use clinical AI applications will begin to move from point solutions to enterprise platforms to demonstrate improvements in these 4 areas: 1) Drive better patient outcomes 2) Manage utilization of scarce resources 3) Improve economics 4) Make clinicians’ lives easier Video by Nassib Chamoun https://vimeo.com/1044414757/de2fe6fae0?share=copy%20 Full Transcript: In […]
Using AI to Understand and Address Post-Discharge Mortality and Readmissions

Experts from Houston Methodist and Health Data Analytics Institute (HDAI) discuss the challenges and advantages of an AI-driven approach. When patients leave the hospital, the hope is they won’t return soon; but that’s often not the case. Post-discharge mortality and readmissions can be a crucial metric in financial and reputational value. Organizations have struggled to […]
LLMs in Healthcare at Scale – the promise, the reality, the cost, and the path forward

By Nassib Chamoun Background As the inevitable transition to an “intelligent health system” accelerates, the development, implementation, and deployment of AI-powered solutions is moving at speeds uncharacteristic of healthcare. Leveraging intelligence in all aspects of healthcare management and operations is becoming essential in helping to address many of the industry’s most pressing challenges, including clinician […]
Healthcare AI Isn’t Magic, But It Can Save Lives

By Arielle Rogg Our CEO Nassib Chamoun recently chatted with podcast host Harry Glorikian about how HDAI came about and how the company has built AI models to address today’s most pressing healthcare issues. Here is a snapshot of what they discussed during the podcast: One of Glorikian’s first questions was whether AI tools will […]
New Research Explores Immuno-oncology Effectiveness for Lung Cancer in Medicare Population

05.21.21 Findings from HDAI and Dana-Farber Cancer Institute Real-world Evidence Study of 20,000 Medicare Patients Shows Shorter Survival Times than Observed in Clinical Trials BOSTON, May 21, 2021 /PRNewswire/ — Health Data Analytics Institute (HDAI) – an innovator in healthcare AI solutions – and researchers at Dana-Farber Cancer Institute today announced publication of findings exploring the effectiveness of immune checkpoint inhibition for […]